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Abstract
PTSD has profound personal, social and economic impact. Understanding factors that influ-
ence strong recovery is a priority for informing the use of limited treatment resources. This
study follows up a preliminary finding from Hoelterhoff and Cheung Chung, Psychiatr Q, 88,
635-651, [30] which found that death anxiety is related to PTSD and suggested that self-
efficacy may mediate this relationship. Specifically, this study examined self-efficacy as a
protective factor in the context of people who have experienced a life-threatening event. 109
undergraduate university students completed self-report questionnaires on, self-efficacy, death
anxiety, trauma and well-being as well as a number of demographic factors. Self-efficacy was
found that to be significantly and inversely related to death anxiety and psychiatric co-
morbidity, but not PTSD. Results were discussed in light of literature regarding death anxiety.
It seems that self-efficacy is related to death anxiety and well-being; however, it interacts with
these processes independently and not as a mediating factor. More research is needed to
understand coping mechanisms that help develop resilience against the negative effects of
death anxiety against PTSD and minimize its detrimental impact on mental health.
Keywords Agency . Protective factors . Self-efficacy . Death anxiety . PTSD . Psychiatric Co-
Morbidity
Introduction
In a previous study done by Hoelterhoff and Cheung Chung [30], a mixed methods investi-
gation examined how death anxiety influenced PTSD and mental health among people who
have experienced a life-threatening event. Data indicated significant correlation between death
Psychiatric Quarterly
https://doi.org/10.1007/s11126-019-09694-5
* Mark Hoelterhoff
mark.hoelterhoff@ed.ac.uk
1 School of Health in Social Science, Medical School, University of Edinburgh, Doorway 6 Teviot
Place, Edinburgh EH8 9AG, UK
2 The Chinese University of Hong Kong, Hong Kong, China
anxiety and PTSD, but not psychiatric co-morbidity. In phase 2 of that study, a qualitative
study attempted to further explore the phenomenological experience of participants with full
PTSD; results indicated that agentic themes emerge in response to the life-threatening event.
Overall these agentic coping mechanisms functioned as protective factors allowing participants
to develop resilience against the effects of death anxiety and minimize its negative impact on
mental health [30]. If agentic protective factors are the key to managing the detrimental effects
of death anxiety, can a sense of control within a strength-based perspective be fundamental to
this process?
Self-efficacy is an idea that addresses issues of control and the belief in oneself as having
the strengths and resources to handle problems that may arise [4, 33, 37]. In Bandura’s social
cognitive theory, perceived self-efficacy to exercise control over potential threats plays a
central role in anxiety arousal. By examining the relationship perceived between self-
efficacy and anxiety arousal, research shows perceived coping “inefficacy” is accompanied
by high levels of subjective distress, autonomic arousal and catecholamine secretion [4].
Analyses of the causal structure of self-protective behaviour show that anxiety arousal and
avoidant behaviour are mainly co-effects of perceived coping inefficacy [2, 4]. This idea is a
key concept to keep in mind when examining the clinical implication of intrusive negative
thinking and anxiety arousal of PTSD.
Currently, there is limited literature that could propose a useful model of therapeutic
resilience (based in part on self-efficacy) which would mediate death anxiety with PTSD
and psychiatric co-morbidity. Previous literature predominantly focuses on death as a specific
fear or anxiety and as something that should be grieved, perhaps in the context of psycho-
therapy [6, 32]. However, previous research has identified components that will help develop a
framework in which to understand the interaction. People’s self-efficacy, then, includes a sense
of competency in relation to death; low competency results in high death anxiety and vice
versa [40]. The emphasis is coping with death itself. Self-efficacy then becomes an issue of
control or at least a perceived level of control over the end of one’s life. People are afraid of
death despite whether or not that awareness fluctuates. Thus, death anxiety is understood as
being controlled by death competency, in other words a death self-efficacy [24, 28, 40].
Previous studies have found self-efficacy to be an important proactive “agentic” factor in
post-traumatic recovery. Self-efficacy has been consistently linked with well-being and im-
proved psycho-social functioning [4, 7, 10, 31]. Specifically, in regard to anxiety, self-efficacy
has been shown to help individuals exert more control over their anxious thought processes [3,
4, 19, 46, 51].The social cognitive model of death anxiety focuses on this type of perceived
self-efficacy. People perceive or believe that they have the ability to prepare for death and the
issues surrounding death. This issue of perceived control correlates with the anxiety around
death. A review of death anxiety literature shows self-efficacy is both a predictor and mediator
of death anxiety [19, 46].
People with low levels of self-efficacy are more likely to report high levels of death anxiety
[11, 50]. People’s beliefs about their own self-efficacy are linked to various determinants of
death anxiety. Indeed, a related review has found that people who are anxious about death also
show a tendency towards hampered belief in self-ability and mental health difficulties [32].
Death anxiety is consistently found to correlate negatively with difficulties in perceptions of
self [1, 16, 35, 38].
The role of self-efficacy with regard to death anxiety appears to tap into a range of skills,
beliefs and attitudes about self and death. If self-efficacy serves as a protective or coping factor
in death anxiety and life-threatening events, it is important to examine the relationship between
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self-efficacy and PTSD. At this stage it is important to propose a theoretical model in light of
the previously mentioned research. Based on the social-cognitive theory of post-traumatic
recovery, the agentic adaptation model can be used to demonstrate the mediational role of self-
efficacy between death anxiety and PTSD/psychiatric co-morbidity. This theory has its roots in
an agentic perspective that views people as self-organising, proactive, self-reflecting and self-
regulating, not just as reactive organisms shaped by traumatic forces or driven by inner
pathology [4]. This agentic model has been applied to PTSD symptomology. This agentic
model would then assert that death anxiety is a result of the reduction of resources that relates
self-efficacy thus impacting PTSD.
The proposed model suggests that a “loss of resources” results from the impact of a life-
threatening event which challenges both physiological and psychological resources. Second,
this loss of resources then triggers self-efficacy as a coping strategy. Thirdly, depending on the
level of self-efficacy, PTSD symptoms will either be manageable or result in clinically high
symptoms of hyperarousal, intrusion and avoidance [7]. Therefore, it can be theorised that the
agentic model can also be applied to death anxiety in a similar fashion to PTSD. Death anxiety
from a life-threatening event creates a loss of resources. As stated earlier, people fluctuate in
their level of awareness of death anxiety; however, the life-threatening event brings the death
anxiety to the forefront of consciousness. The death anxiety is then akin to the lack or loss of
resources in the adaptation model of PTSD [18]. In the agentic process, self-efficacy would be
triggered as a coping resource for the individuals. Therefore, a person’s ability to remain
resilient against death anxiety in the face of a life-threatening event would be mediated by self-
efficacy.
The agentic model as applied to the experience of death anxiety is a relevant and slightly
modified model of the social cognitive perspective on PTSD. The reason it has been adapted
for the purpose of studying death anxiety is that literature suggests death anxiety has a negative
effect of psychological resources [26, 48]. According to the literature, death anxiety affects
general psychological functioning; therefore, using the agentic model, self-efficacy should act
as a mediator. Higher self-efficacy should mediate the effects of death anxiety resulting in
lower mental health difficulties. Conversely, lower self-efficacy would be less effective in
mediating the impact of death anxiety on mental health. In order to develop this model of death
anxiety resilience further, research needs to demonstrate that death anxiety is mediated by self-
efficacy and thus has demonstrable effects on PTSD and mental health outcomes.
Previous studies have shown self-efficacy and factors relevant to self-efficacy are signifi-
cantly related to death anxiety [1, 11, 16, 19, 32, 35, 38, 50, 46]. The main conclusion from
this research is that higher self-efficacy should act as an effective mediator of death anxiety on
mental health, thus the rationale for the proposed agentic model of death anxiety resilience.
Research Aims
The aim of this study is to explore the relationship between death anxiety, self-efficacy, PTSD
and psychiatric co-morbidity. Thus, this study will examine three hypotheses
1) Death anxiety is significantly related to self-efficacy
2) Self-efficacy is significantly related to PTSD
3) Self-efficacy is significantly related to psychiatric co-morbidity
Psychiatric Quarterly
The following model will be tested. See Fig. 1.
Method
Participants
A population of 109 students at a Lithuanian university participated in the study (M= 26, F =
83) with an average age of 20.63 (SD = 1.86). Almost all (93.6%) were single. Most (66.1%)
were Lithuanians and the rest were predominantly from Northern and Eastern Europe. Over
half (62.4%) were an upper level year group (years 2 and 4) at the time of the study.
Procedure
Prior to recruitment, significant time was taken to create both Lithuanian and Russian versions
of the questionnaires. This was carefully done by developing two translation teams each
comprised of 4 members of the university translation club. They were supervised directly by
the first author. Upon creation of the questionnaires, they were reviewed by member of the
university linguistics department for accuracy. The questionnaires were then back translated
into English and compared to the original assessments to improve the accuracy of representing
the original English questionnaires. The questionnaires were available in English, Lithuanian
and Russian. Although English is the language of instruction, the researcher intended that
participants could choose to take the questionnaires in the language in which they were most
comfortable.
Prior to recruitment, the study was submitted to the university International Review Board
for approval and was given clearance to be conducted after all ethical and procedural issues
were considered. Participants were recruited during a social science module lecture with the
tutor’s permission. To secure credits for that module, students engaged in different academic
Notes: H1 to H3 are hypotheses 1 to 3
Self-
Efficacy
Death
Anxiety
PTSD
Psychiatric Co-
morbidity
H1
H2
H3
Fig. 1 Hypothesis Model H1-H3
Psychiatric Quarterly
activities, one of which was to participate in a research project. Students also had the option
not to engage in any of these activities.
This researcher gave out the self-administered questionnaires during the lecture and was
available to participants to clarify unfamiliar terms. Student volunteers collected the surveys.
This researcher then explained to the class the theory being tested as an additional supplement
to the module material.
Questionnaires consisted of:
1. Participant demographics
2. Posttraumatic Stress Diagnostic Scale (PDS)
3. General Health Questionnaire-28 (GHQ-28)
4. Death Anxiety Scale (DAS)
5. The General Perceived Self-efficacy Scale (PSSS)
Participants who indicated at the beginning of the demographic questionnaire that they had
never experienced a life-threatening event were assigned to the control group. If participants
answered “no” to having a traumatic event, they were asked to bypass the PDS. They were still
asked to complete the assessments on the PSSS, DAS and the GHQ-28.
Measures
1) Demographic information:
& Age
& Gender
& Year level
& Marital status
& National identity
& Homesickness
& Stress from independent living
& Comfortable with living arrangements
& First time living without parents
& Coursework deadline within the next 7 days
2) The Posttraumatic Stress Diagnostic Scale (PDS) [18] assesses symptoms
resulting from experiencing a traumatic event, according to DSM-IV criteria.
Participants were classified into the following groups: ‘no PTSD’ (not meeting
the diagnostic criteria) and ‘PTSD’ (meeting all required symptom criteria for
re-experiencing, avoidance and hyperarousal along with helplessness, terror and
an impact upon daily function). In part I, information was gathered about the
trauma itself. Participants are asked to identify whether they have experienced
any past life-threatening events including natural disasters, accidents, physical or
sexual assault, combat or exposure to a war zone, sudden violent or unexpected
death of someone close, and life-threatening injury. Questions were asked on
trauma exposure characteristics (if yes); number of events, most severe trauma,
how long ago trauma happened, physically injured, someone else injured, was
life in danger, someone else’s life in danger, feel helpless, feel terrified?
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Part II assesses PTSD symptoms resulting from having experienced the most life-threatening
experience. It is composed of the 17 questions contained in the DSM-IV diagnostic criteria and
generates three subscales: re-experiencing, avoidance and hyperarousal. Participants were
asked to rate the severity of symptoms: 0 = not at all, 1 = once a week or less/once in a while,
2 = 2 to 4 times a week/half the time, 3 = 5 or more times a week/almost always. Excellent
internal consistency (alpha = 0.97), and test-retest reliability (0.96) have been recorded over a 2
to 3 day period. The PDS is known to be strongly correlated with other measures of PTSD
such as the Mississippi Scale (0.93) and the Impact of Event Scale (0.90). This scale has shown
good reliability, validity and good agreement with the Structured Clinical Interview for
Diagnosis (kappa = 0.65, agreement = 82%, sensitivity = 0.89 and specificity = 0.75).
3) The General Health Questionnaire-28 (GHQ-28) [25] measures general psychological
morbidity and global dysfunction, and yields four subscales: somatic problems, anxiety,
social dysfunction and depression. The GHQ-28 has shown a sensitivity value of 88% at a
specificity of 84.2% and an overall misclassification rate of 14.5%.
4) The Death Anxiety Scale (DAS) is self-report instrument for measuring death anxiety
which consists of 15 true or false items. Templer’s 15 item scale, first published in 1970,
has been used extensively and has been translated into many different languages. It has
been shown to have test-retest reliability of 0.83, and an internal consistency coefficient of
0.73 (Templar, 1970).
5) Perceived Self-Efficacy Scale
The scale was created to assess perceived self-efficacy with the aim to predict coping with
daily problems, as well as adaptation after experiencing all kinds of stressors [42]. It is self-
administered and scoring responses are made on a 4-point scale and then summed. The
responses to all 10 items yield the final composite score with a range from 10 to 40. The
construct of Perceived Self-Efficacy reflects an optimistic self-belief; beliefs that one can
perform difficult tasks, and cope with adversity in various domains of human functioning.
Perceived self-efficacy taps internal-stable attributions and facilitates goal-setting, effort in-
vestment, persistence in face of barriers and recovery. Perceived self-efficacy is an operative
construct and is related to subsequent behaviour and, therefore, is relevant for clinical
treatment [42]. The measure has been used internationally with success for two decades and
in samples from 23 nations [42]. The scale is uni-dimensional and criterion-related validity is
documented in numerous correlation studies where positive coefficients were found with
favourable emotions, dispositional optimism, and work satisfaction [42]. Negative coefficients
were found with depression, anxiety, stress, burnout, and health complaints [42].Therefore it
can be taken to predict adaptation after traumatic life changes, but it is also suitable as an
indicator of quality of life at any point in time. The Self-Efficacy scale was analysed using item
alpha reliability and showed good internal consistency (α = 0.843).
Data Analysis Plan
Descriptive statistics were used to describe the demographic information of the participants. T-
test, Chi-Square and multivariate analysis variance were used to compare the life-threatening
event and control groups in terms of the differences of mean and percentage scores. Correla-
tion coefficients including point biserial correlation (rpb) were used to establish the relationship
between demographic variables and outcome variables. Point biserial correlation was used
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when one of the variables in the correlational analysis was dichotomous. Partial Least Squares
(PLS) analysis was used to examine the interrelationship between the constructs in the
hypothesized model. The mediation procedure recommended by Baron and Kenny [5] and
the Sobel test were used to investigate mediational relationships identified in the final model.
The assumptions and diagnostics related to multiple linear analysis were examined. Three
subscales of the GHQ-28 (somatic, anxiety, social dysfunction) were subjected to a logarithmic
transformation. When performing regression analysis to examine mediational relationships,
one outlier was detected during the exploration of diagnostics (Mahalanobis ≥3 SD) and was
subsequently removed from the analysis. Following exploration and transformation, assump-
tions relating to multivariate normality, linearity and homoscedasticity were met. Regression
imputation was used in order to address the missing data. In this study, less than 1% of the
missing data was imputed which was deemed to be acceptable in literature [41].
Results
Fifty-two (47.7%) participants reported life-threatening events and 57 (52.3%) did not. Almost
a fifth (17.6%) experienced one event while almost half (49%) at least two events. Remaining
participants experienced three or more events. According to the PDS, 24 people (22%) met
diagnostic criteria for full PTSD and 28 (25.6%) did not. Table 1 shows the demographic
information of the PTSD, no-PTSD and control groups.
There were no significant differences between groups participating in the study when
considering age [F(2,73) = 1.75, ns], gender (Fisher’s exact test χ2 = 5.44, df = 2, ns), year
level (χ2 = 1.08, df = 2, ns), marital status (Fisher’s exact test χ2 = 3.36, df = 2, ns), nationality,
(χ2 = 4.42, df = 2, ns), degree of homesickness [F(2,73) = 0.82,ns], stress from independent
living [F(2,73) = 1.75, ns], how comfortable they were with living arrangements [F(2,73 =
2.45, ns], first time living without parents (χ2 = 4.56, df = 2, ns), or having a coursework
deadline in 7 days (Fisher’s exact test χ2 = 0.21, df = 2, ns).
Table 2 shows the event which was most bothersome in the group of participants who
experienced a life-threatening event. Comparing the life-threatening groups, there were no
significant differences between the full PTSD and no-PTSD group regarding the number of
events (t = 1.48, df = 49, ns). In addition, both the full PTSD group and no-PTSD group on
average experienced the life-threatening event which bothered them the most just over four
years ago (t = 0.26, df = 50, ns). The frequencies of identified experiencing specific life-
threatening events between groups were quite similar, see Table 2.
Table 3 summarises the means and standard deviations of psychiatric co-morbidity, death
anxiety, and self-efficacy. GHQ has a clinical cut-off at 4; DAS has clinical case cut-off.
Results showed significant differences between the three groups for anxiety [F (2,105) = 3.42,
p < 0.05]. Post Hoc (LSD) analysis showed that the full PTSD group had higher levels of
anxiety than the no- PTSD group (p < 0.05). There was also a significant difference between
the three groups for social dysfunction [F (2,105) = 6.14, p < 0.01], full PTSD higher in
severity than no-PTSD (p < 0.01) and control (p < 0.01) (Post Hoc LSD). In addition, there
was a significant difference in depression [F (2, 105) = 6.44, p < 0.01], full PTSD was higher in
severity than no-PTSD (p < 0.01) and control (p < 0.01) (Post Hoc LSD). However, there were
no significant differences for somatic problems [F (2, 105) = 3.00, ns]. There was no signif-
icant difference between PTSD, no-PTSD or control on death anxiety [F (2,105) = 3.03, ns] or
self-efficacy [F (2,105) = 1.75, ns].
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Prior to the PLS analysis of establishing the relationship between death anxiety, self-
efficacy, PTSD and psychiatric co-morbidity, the demographic variables needed to be con-
trolled. To this end, correlation coefficients including point biserial correlations (rbp) were
carried out to see which demographic variables were related to outcome. The results show that
Table 1 Demographic details
PTSD group No PTSD group Control
Mean SD Mean SD Mean SD
Age 20.58 1.74 20.35 2.07 20.78 1.75
N % N % N %
Male
Female
2
22
8.3
91.7
10
18
35.7
64.3
14
43
24.6
75.4
Level
Year 1
Year 2
Year 3
Year 4
4
3
8
9
16.7
12.5
33.3
37.5
9
3
3
13
32.1
10.7
10.7
46.4
17
5
12
23
29.8
8.8
21.8
40.4
Marital Status
Single
Married
Co-habituating
23
1
95.8
4.2
24
2
2
85.7
7.1
7.1
55
1
1
96.5
1.8
1.8
What country is passport from?
Lithuania
Latvia
Belarus
Russia
Ukraine
USA
Other
14
3
2
1
2
2
58.3
12.5
8.3
4.2
8.3
8.4
23
2
2
1
82.1
7.1
7.1
3.6
35
2
6
5
2
61.4
12.3
3.5
10.5
8.8
3.6
Mean SD Mean SD Mean SD
Homesickness 3.56 1.71 2.94 0.96 3.40 1.79
Stress from independent living 2.57 1.80 1.91 1.01 2.13 1.37
Comfort with living arrangements 5.21 1.27 6.20 0.76 5.39 1.26
N % N % N %
First time without parent
No
Yes
12
12
50
50
20
8
71.4
28.6
42
15
73.7
26.3
Deadline in 7 days
No
Yes
17
7
70.8
29.2
22
6
78.6
21.4
51
6
89.5
10.5
Table 2 Life-threatening event which bothered the most
PTSD Group No PTSD group
Life threatening events Number % Number %
Serious accident 6 25.0 8 28.6
Physical assault by family member or someone you know 5 20.8 5 17.8
Physical assault by a stranger 5 20.8 9 32.1
Sexual assault 1 4.2 0 0
Life-threatening illness 7 29.2 6 21.5
Mean SD Mean SD
Onset of the event (in months) 55.37 52.16 51.50 54.12
Number of life-threatening events 2.73 1.35 2.21 1.16
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gender was the only significant variable associated with PTSD, possibly due the difference in
number for of men and women in the sample. Unfortunately, due to the fact that PLS analysis
requires multiple indicators for each construct, the current research could not develop the
construct of demographic information with gender being the only indicator. Ergo, gender was
not included in the PLS analysis, however PTSD scores were compared between males and
females; results showed female participants reported more PTSD symptoms than males
(female mean = 4.08, sd = 1.59 vs. Male m = 2.38, sd = 1.59, t = −2.98, df = 45, p < 0.01).
To test the hypothesized model of the relationships between death anxiety, self-efficacy,
PTSD and psychiatric co-morbidity, we carried out partial least squares (PLS) analysis using
PLS-Graph 3.00 [13, 14]. PLS is an alternative to standard structural equation modelling
(SEM). PLS models, like SEM models, incorporate latent variables (constructs) with multiple
indicators. One of the advantages of PLS over SEM, and a major factor in choosing it for the
current work, is that, in contrast to SEMwhich requires a large sample size, it can be used with
modest sample sizes even for relatively complex models. Arguably, the sample size in this
study was too small for SEM.
Unlike SEM, PLS makes no distributional assumptions and models may incorporate
formative, as well as reflective, indicators. Having multiple indicators of the construct would
increase the reliability of what the construct represents. PLS generates outer and inner model
estimates. The outer model estimates refer to the loadings or weights for each indicator and
show how strongly it relates to the construct. The inner model estimates refer to the linear
relationship between constructs by means of regression coefficients. PLS does not generate a
test of model fit but provides estimates of path coefficients for the paths in the model and tests
of whether these path coefficients differ significantly from zero. The tests were carried out
using bootstrap re-sampling to generate t statistics. Two hundred bootstrap samples were
produced.
Less than 1% of responses were missing due to participants omitting questionnaire items.
PLS have no procedures for dealing with incomplete observations so regression imputation
was used to replace the missing data. Regression imputation has been shown to be a valid
method in dealing with missing data [41]. It should be noted that PLS analysis requires
multiple indicators for each construct. Therefore, in situations where there are not specific
subscales, multiple indicators needed to be created. In order to provide multiple indicators for
death anxiety and self-efficacy, 3 item and 2 item parcels were computed respectively. Death
anxiety indicators were created by using questions that reflected three types; fear of dying,
Table 3 Mean and standard deviations for DAS, SE, and GHQ-28
PTSD Group No PTSD Group Control
Mean STD Mean STD Mean STD
GHQ-28
Somatic 17.16 4.39 14.78 3.24 15.43 3.65
Anxiety 16.79 5.38 13.46 3.28 15.61 4.94
Social Dysfunction 17.33 2.89 14.85 2.12 15.57 2.66
Depression 13.41 5.31 9.60 2.91 10.56 3.64
DAS
Total 8.70 2.88 6.96 2.78 7.61 2.28
Self-efficacy
Total 30.68 5.23 33.13 3.11 30.80 3.98
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death caused by external circumstances and thinking about death. The indicators of self-
efficacy were created by taking the items from the scale and dividing them into two items:
SE1, SE2.
Table 4 shows the estimated loadings of the scale items death anxiety (afraid to die,
thoughts of death, & external death), self-efficacy (self-efficacy 1 and self-efficacy 2), PTSD
(Intrusion, avoidance & hyperarousal) and psychiatric co-morbidity (somatic problems, anx-
iety, social dysfunction & depression). Reflective indicators with loadings that were not
significantly different from zero were removed to ensure construct validity. Accordingly, the
indicator of thinking about death was dropped from the PLS analysis. The correlation matrix
for the indicators used in the modelling is given in Table 5. The final structural model can be
seen in Fig. 2. The resulting path coefficients for relationships between constructs are shown in
the figure which also indicates their significance. Unlike SEM, PLS analysis does not tell us
the degree of model-fit. Instead, it examines predictive capability of the model characterized
by the presence of strong construct loadings (>0.60), standardized path coefficients (>0.20)
and at least moderate R2 values. Most of the construct loadings were strong. The path
coefficients of the significant paths were also strong (see later) and the average R2 of the
overall model was 0.0626 (average communality = 0.5306, average redundancy = 0.0381).
Death anxiety was significantly associated with self-efficacy (B = -0.2700, SE = 0.1571,
p < 0.05) which was in turn associated with psychiatric co-morbidity (B = -0.3760, SE =
0.1299, p < 0.05).
Conceptually, path results suggest that participants’ self-efficacy mediated the relationship
between death anxiety and psychiatric co-morbidity. To verify this, we examined mediation
using the regression procedure recommended by Baron and Kenny [5]. To begin with,
significant association between the independent variable (IV) and dependent variable (DV)
need to be established. Then, for complete mediation, three conditions need to be met: a) The
IV must be significantly associated with the mediator, b) the mediator must be significantly
associated with the DV, c) the relationship between the IV and DV becomes non-significant
when the mediator is controlled. For partial mediation, the three conditions remain the same
except that for condition c, the relationship between the IV and the DV remains significant
when the mediator is controlled.
Table 4 Loadings and weights of Indicators on the constructs (latent variables)
Latent variable Indicatora SE Loading
Death anxiety Afraid to die 0.3633 0.7199*
Thoughts of death 0.3477 0.5543†
External death 0.3829 0.8183*
Self-efficacy Self-efficacy 1 0.1235 0.8835**
Self-efficacy2 0.2582 0.8354*
PTSD Intrusion 0.1491 0.9149**
Avoidance 0.1401 0.9718**
Hyperarousal 0.0992 0.8812**
Psychiatric co-morbidity Somatic problems 0.2155 0.6385*
Anxiety 0.0937 0.8683**
Social dysfunction 0.1207 0.8343**
Depression 0.1283 0.8008**
a All indicators are reflective indicators
*p < 0.05; **p < 0.001; Significance levels are based on bootstrapped standard errors
† Dropped items
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Results showed that death anxiety (IV) was not correlated with psychiatric co-morbidity
(DV) (B = 0.075, SE B = 0.039, Beta = 0.265, ns) suggesting that the first condition of the
mediation analysis was not met. Given this, the rest of the mediation procedure did not need to
be carried out. In other words, self-efficacy was not a mediator between death anxiety and
psychiatric co-morbidity. This lack of mediation was confirmed using the Sobel test. The
results showed that self-efficacy did not mediate the relationship between death and psychiatric
co-morbidity (Z = 0.93, ns).
Discussion
The aim of this study was to explore the relationship between death anxiety, self-efficacy,
PTSD and psychiatric co-morbidity. Further, specifically to look at an agentic model of death
anxiety resilience in the context of PTSD. The results highlight that self-efficacy is related to
death anxiety supporting the first hypothesis of this study. This result is consistent with
previous research and demonstrates a connection between self-efficacy and death anxiety [1,
11, 16, 19, 20, 21, 32, 35, 38, 50, 46].
Surprisingly, self-efficacy was not found to be related to PTSD and the second hypothesis
was rejected. This specific finding is inconsistent with previous research which identifies self-
efficacy as related to posttraumatic symptoms [4, 7, 39, 49]. However, some studies have
indicated that other factors in combination with self-efficacy demonstrate greater influences on
PTSD [8, 12, 15]. The third hypothesis was supported, however, and self-efficacy influences
psychiatric co-morbidity. Other research has shown self-efficacy is correlated positively with
mental health [4, 7, 27].
One strength of this study is that the sample population experienced a range of life-
threatening events, whereas many studies have examined very specific types of trauma.
Despite other studies’ focus on specific populations and subsequent findings, this study has
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efficacy 1
Self-
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yielded similar results. This indicates that the findings can be seen as somewhat robust in that it
is not event or setting specific. While on one hand this may be considered a strength, it may
conversely be seen as a weakness. The results of study show self-efficacy is related to
psychiatric co-morbidity, but not PTSD. This is surprising, considering the previously men-
tioned literature review on self-efficacy and PSTD. Research shows the association between
self-efficacy and PTSD is transient. Self-efficacy is associated with short term adjustment to
traumatic events; however, this association tends to diminish over time [23, 43]. Yet, other
studies suggest that self-efficacy and trauma may not be closely associated. For example, an
increase in self-efficacy was not followed by improvement in PTSD symptoms [17, 47].
However, if there are ample studies showing a likely link between self-efficacy and PTSD
as previously mentioned, it begs the question as to why the relationship was not evidenced in
this study. Going back to trauma types, this may have influenced the results. This is not a study
on a specific type of traumatic event, e.g., sexual abuse, PTSD and self-efficacy. Hence the
broad nature of trauma types and life-threatening events in this sample may have reduced the
strength of the relationship. Additionally, the age of the sample may have influenced the lack
of connection of self-efficacy to PTSD. Interestingly, research has been inconsistent on the
effects of age on PTSD; some research has shown the severity of PTSD increases with age,
while others suggests context for trauma is more significant [36, 44].
The connection to psychiatric co-morbidity indicates a strong relationship to self-efficacy
and may be symptom specific, but not necessarily specific to PTSD symptoms. In other words,
self-efficacy, in actuality, relates more to symptoms of general psychological difficulties &
global dysfunction. It can be argued that self-efficacy is more relevant to general psychological
difficulties or global dysfunction versus being specific to PTSD. For example, it was found
that self-efficacy related to the immediate mental health difficulties from trauma, but not the
long-term symptomology of PTSD [9]. How is this plausible? As stated earlier, self-efficacy
relates to general anxiety arousal on the whole. Perhaps what should be considered is that self-
efficacy regulates a more general sense of health anxiety as stated in the cognitive behavioural
literature ([20], 1997). This is also possible because PTSD and psychiatric co-morbidity could
be considered as two different syndromes. In any case, in this sample self-efficacy is related to
psychiatric co-morbidity.
Self-efficacy did affect psychiatric co-morbidity, although not in the way proposed by this
researcher. Death anxiety relates to self-efficacy; however, self-efficacy did not mediate the
impact of death anxiety on psychiatric co-morbidity. This was surprising because previous
studies suggest that death anxiety is positively related to mental health. Ergo, the degree to
which mental health problems are exacerbated by death anxiety should be mediated by self-
efficacy. Perhaps what can be said is that although death anxiety directly influences PTSD,
self-efficacy improves general mental health. By decreasing mental health difficulties, in
essence, the relationship of death anxiety to PTSD may be indirectly influenced via self-
efficacy. Literature shows that when death anxiety is controllable via self-efficacy and the
person has less psychiatric co-morbidity, it improves the perceived level of manageability
regarding PTSD [39]. Conversely, if people have uncontrollable death anxiety due to low self-
efficacy and high psychiatric co-morbidity, they will have a more difficult time managing
PTSD.
However, in regard to the earlier stated model of death anxiety resilience, it should be noted
that self-efficacy was not demonstrated to be a mediator; it does not carry the influence of
death anxiety to psychiatric co-morbidity which contradicts the agentic model of death anxiety.
Self-efficacy relates to death anxiety independently of self-efficacy relating to psychiatric co-
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morbidity implying that these are separate psychological processes. It was proposed that self-
efficacy is a mediator in the agentic model, but the results do not support this. In light of the
results that self-efficacy contributes to death anxiety and contributes to psychiatric co-morbid-
ity, it should be considered that this is an additive, not mediational, model of death anxiety.
This is not inconsistent with Bandura’s model of self-efficacy because, in its essence, it is an
intrinsic human response to cope with death anxiety and it is an intrinsic human response that
also copes with psychiatric co-morbidity [20]. If indeed death anxiety and psychiatric co-
morbidity are two different psychological phenomena, even though self-efficacy is related to
both, they are different processes. One way to consider the role of self-efficacy is as a “surge
protector” that buffers against ordinary psychological reactions so they do not become
maladaptive. The results show a negative relationship of self-efficacy to death anxiety and
psychiatric co-morbidity. Self-efficacy seems to protect against “normal” emotional affect
from becoming maladaptive, without this protection it could develop into psychopathology.
Returning to the subject of PTSD, perhaps it does not demonstrate the same effect because
it results from an extraordinary event. According to the results of this study, self-efficacy does
not necessarily buffer against the distress related to PTSD. However, the agentic model is not
fully contradicted by this study. Perhaps death anxiety and loss of resources are quite different.
As stated earlier, this study is based on young adults, not necessarily representing the
population used in Bandura’s research regarding PTSD. In his model, self-efficacy is some-
thing that develops across the lifespan and is related to cognitive development [3]. In other
words, the use of self-efficacy specifically with those suffering from PTSD may not be as
developed with a younger population.
It’s important to consider academic stressors influencing the sample population. However,
the results do not support this idea; none of the added demographic information (Homesickness,
Stress from independent living, Comfort with living arrangements, first time living without
parents, Coursework deadline within the next seven days) demonstrated significance. Consid-
ering limitations of this study, there may be other issues of distress that have not been accounted
for that are affecting this sample. These may be factors that exist within the general population.
Data from theWorld Health Organization rank Lithuania as one of the worst standardized death
rates from suicide and self-inflicted injury [29]. This very high rate of suicide is complex and
difficult to determine in its causality; however, it does lend itself to speculation on overall
mental health difficulties. Mortality from mental disorders (including alcohol dependency) was
the highest in Europe in 1995 [29]. The registered prevalence ofmental diseases among the total
population was 4.2% in 1998 and epidemiological studies show that almost 500,000 people
may need psychological, psychotherapeutic or psychiatric counselling [29]. Obviously, these
are generalisations about the people of that region, but should be considered as potential
influences on the levels of psychiatric co-morbidity in the sample.
Considering some of the limitations of this study, it is important to note that this is not a
longitudinal study; therefore, causality cannot be determined from the results. Although it
would be beneficial for future research, in this case it was not practical. Due the specifics of the
setting and the short-term placement of this researcher, longitudinal follow-up would have
been very difficult and labour intensive. Regardless of the benefits of a longitudinal design, the
other themes of religious coping and existential attitude needed to be explored. Unfortunately,
it would not be feasible to do a longitudinal study of all three themes. In addition, due to this
being a cross-sectional design, it cannot be established as to whether this is a state or trait
phenomenon. This is indeed a limitation in a majority of death anxiety research [34, 45]. A
cross-sectional study does not allow for this type of discussion. Finally, PLS analysis does not
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establish causality; it works with regression and associations between variables. In other
words, it is correlational and directional, but not causal. In light of this, the results must be
interpreted in light of the aforementioned design limitations.
One final consideration is the cross-cultural implications for self-efficacy. This researcher’s
anecdotal experience of the culture led to an investigation as to whether self-efficacy is actually
more of a western concept. Indeed, literature does show self-efficacy is more congruent with a
western focus on self-reliance, achievement and mastery [22]. These values may not be as
socially desirable in the northern and eastern European context. Future research should explore
whether self-efficacy is indeed a universal coping mechanism relevant cross-culturally, spe-
cifically for death anxiety and mental health.
Conclusion
This study has demonstrated the role of self-efficacy as influencing both death anxiety and
psychiatric co-morbidity, separately. However, the role of self-efficacy between death anxiety
and PTSD is complicated. The social cognitive perspective for understanding death anxiety may
still be useful. It appears as though self-efficacy switches on for death anxiety and psychiatric co-
morbidity, but not for PTSD. Psychologists and mental health workers should acknowledge the
clinical reality of death anxiety among victims of trauma. It is indeed linked to well-being and
should be considered within a psychotherapeutic treatment plan. Psychologists and mental health
workers should both recognise and encourage victims of trauma to utilise coping mechanisms.
These may include self-efficacy as a way to buffer against death anxiety and promote resilience to
it. The results do indicate a relationship there and further research could explore interventions that
support people who’ve suffered traumatic events by bolstering self-efficacy.
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